EMILIN1 and ovarian carcinoma: Pivetta et al. provided direct evidence for this mechanism in human cancers, showing that neutrophil elastase-mediated cleavage impairs EMILIN-1′s tumor suppressor function and that EMILIN-1 degradation occurs in sarcomas and ovarian cancer specimens [37].